Precision BiosciencesDTIL
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 48 institutions reported holding Precision Biosciences Inc. (DTIL) in their 13F filings, down 7 from Q4 2024. 6 opened new positions and 12 sold out. The largest holders were Lynx1 Capital Management LP ($3.7M), Aquilo Capital Management, LLC ($3.5M) and Tang Capital Management LLC ($3.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Precision Biosciences Inc.
- CUSIP
- 74019P207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.3M |
| Exits | 12 | $2.8M |
All 13F filers, Q4 2024 → Q1 2025: 767,850 shares bought and 861,075 shares sold, net −93,225 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Lynx1 Capital Management LP | 1.31% | No change | 766,051 | $3.7M |
| Aquilo Capital Management, LLC | 9.34% | Add +35.4% | 726,149 | $3.5M |
| Tang Capital Management LLC | 0.18% | No change | 673,332 | $3.2M |
| Vanguard Group Inc. | 0.00% | Add +1.0% | 281,083 | $1.3M |
| Acadian Asset Management LLC | 0.00% | No change | 248,620 | $1.2M |
| Boothbay Fund Management, LLC | 0.03% | New | 200,000 | $954K |
| Balyasny Asset Management L.P. | 0.00% | New | 189,665 | $905K |
| Renaissance Technologies | 0.00% | Reduce -24.4% | 82,977 | $396K |
| Geode Capital Management, LLC | 0.00% | Add +14.2% | 73,687 | $352K |
| Millennium Management | 0.00% | New | 65,586 | $313K |
| Tejara Capital Ltd | 0.14% | Add +185.2% | 60,427 | $288K |
| UBS Group AG | 0.00% | Reduce -16.9% | 57,027 | $272K |
| BlackRock, Inc. | 0.00% | Reduce -0.6% | 54,819 | $261K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -3.3% | 53,631 | $256K |
| Northern Trust Corp. | 0.00% | Add +16.1% | 43,027 | $205K |
| Moloney Securities Asset Management, LLC | 0.03% | Reduce -51.2% | 42,866 | $204K |
| Royal Bank of Canada | 0.00% | Reduce -5.4% | 40,000 | $191K |
| Commonwealth Equity Services, LLC | 0.00% | Add +192.7% | 37,155 | $177K |
| State Street Corp. | 0.00% | No change | 22,042 | $105K |
| Two Sigma Investments, LP | 0.00% | New | 13,565 | $65K |
| Morgan Stanley | 0.00% | Add +57.9% | 12,271 | $59K |
| Bleichroeder LP | 0.02% | New | 12,077 | $58K |
| Miller Financial Services LLC | 0.07% | New | 10,000 | $48K |
| Allworth Financial LP | 0.00% | No change | 4,769 | $26K |
| National Bank of Canada | 0.00% | Add +25.0% | 5,000 | $24K |
| Vivo Capital, LLC | 0.00% | No change | 4,675 | $22K |
| NFSG Corp | 0.00% | No change | 1,600 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -65.2% | 1,500 | $7K |
| Cwm, LLC | 0.00% | No change | 1,005 | $5K |
| SBI Securities Co., Ltd. | 0.00% | Add +5.6% | 470 | $2K |
| Barclays PLC | 0.00% | Reduce -86.6% | 384 | $2K |
| Rhumbline Advisers | 0.00% | No change | 275 | $1K |
| Bank of America Corp. | 0.00% | Reduce -99.5% | 132 | $630 |
| FMR LLC | 0.00% | Reduce -85.7% | 100 | $477 |
| SouthState Bank Corp | 0.00% | No change | 95 | $453 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | No change | 69 | $329 |
| BNP Paribas Financial Markets | 0.00% | Reduce -63.8% | 55 | $262 |
| Wells Fargo & Company | 0.00% | No change | 35 | $167 |
| Ameliora Wealth Management Ltd. | 0.00% | No change | 33 | $157 |
| NewEdge Advisors, LLC | 0.00% | No change | 22 | $103 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 12 | $57 |
| JPMorgan Chase & Co. | 0.00% | No change | 8 | $38 |
| Investors Research Corp | 0.00% | No change | 8 | $38 |
| MAI Capital Management | 0.00% | No change | 7 | $34 |
| Farther Finance Advisors, LLC | 0.00% | No change | 4 | $18 |
| Legacy Wealth Managment, LLC | 0.00% | No change | 3 | $15 |
| Harbour Investments, Inc. | 0.00% | No change | 3 | $14 |
| Tsfg, LLC | 0.00% | No change | 3 | $0 |
"% of holder's portfolio" is DTIL's weight in each manager's 13F, not the share of Precision Biosciences Inc. the manager owns.